Risks and benefits of erythropoietin stimulating agents in cancer patients

Nabhani-Gebara, Shereen (2010) Risks and benefits of erythropoietin stimulating agents in cancer patients. Hospital Pharmacy Europe(50), pp. 38-39. ISSN (print) 1477-1896

Full text not available from this archive.
Item Type: Article
Research Area: Cancer studies
Faculty, School or Research Centre: Faculty of Science (until 2011)
Faculty of Science (until 2011) > School of Pharmacy and Chemistry
Depositing User: Davina Omar
Date Deposited: 08 Jan 2013 13:31
Last Modified: 17 Jan 2013 13:47
URI: http://eprints.kingston.ac.uk/id/eprint/24485

Actions (Repository Editors)

Item Control Page Item Control Page